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Introduction
Neuropathic pain (NP) arises from complex changes involving the peripheral and/or central nervous systems in response somatosensorial system injury [1] . Its main behavioral feature is the presence of hyperalgesia and allodynia, leading to impaired functional and cognitive capacities, motor deficits, and a reduction in the quality of life [2] . However, the underlying mechanisms remain unclear.
Increased nociceptive input occurs due to an imbalance between facilitatory and inhibitory synaptic mechanisms driven by upregulation and chronic activation of receptors [3] . Glial cells play an essential role for dealing with injury by changing their phenotype from a basal to a pro-inflammatory state by releasing several neuroimmune mediators, such as tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), calcitonin gene-related peptide (CGRP), and substance P (SP) [4, 5] . Furthermore, while the upregulation of key neurotrophic factors is needed to maintain cell integrity, they also promote sensitization of afferent terminals in chronic pain conditions, giving rise to aberrant nociceptive inputs that modulate pain signaling throughout the nociceptive pathways [6] . Therefore, neuromodulatory strategies for modulating hypernociceptive inputs are important in preventing and treating chronic pain conditions. Transcranial direct current stimulation (tDCS) is a safe, non-invasive technique that modulates neuronal thresholds with anodal and cathodal currents that increase or decrease cortical excitability, respectively [7] . The effects of a weak electrical current delivered over the scalp depend on the brain regions, electrode diameters, and polarity applied; its effects can persist for hours or days [8] . While the short-term effects of tDCS are mediated by ionic channel modulation, the long-term effects are mediated by N-methyl-D-aspartate (NMDA) receptors [9] . Moreover, bimodal tDCS applied over the scalp has been reported to revert inflammatory and chronic stress-induced pain in rats [10, 11] .
Physical inactivity contributes to the development of cardiovascular diseases, diabetes, depressive symptoms, and chronic pain [12] . Systemic effects of exercise also play a neuroprotective role in rats in inflammatory and chronic pain models [13, 14] and increase hippocampal volumes in older adults [15] . Even though the underlying mechanisms of the prophylactic and therapeutic effects of exercise remain unknown, opioid antagonists have been reported to alleviate exercise-induced analgesia, suggesting that the aerobic exercise effects are, at least partly, due to activation of the opioid system [16] . Furthermore, physical exercise induces IL-6 mRNA and protein production in the skeletal muscle, leading to an increase in the release of antiinflammatory cytokines (IL-4 and IL-10) and the inhibition of IL-1β and TNF-α synthesis [17] .
Despite these top-down and bottom-up neuromodulatory techniques need further elucidation, studies targeting to investigate the effects of tDCS or exercise have shown resembling effects mediated by both interventions, which includes, opioid, monoamines, endocannabinoids, glutamate releasing, and corticospinal tract modulation parameters [18] [19] [20] . Regarding these modulations of intracortical inhibition or facilitation parameters, Stagg et al. [21] have demonstrated that anodal tDCS applied upon motor cortex (M1) lead to a reduction of GABA levels, whilst cathodal stimulation reduced the glutamate levels. These results suggest that the effects provided by anodal or cathodal stimulation might have effects upon neuronal circuitry, similar those triggered by exercise.
Neuromodulation techniques combined with exercise may be an alternative noninvasive method to improve functional recovery [22] . However, little is known about the combined effects of tDCS and exercise on pain relief. We aimed to investigate if the association between tDCS and exercise provide more pronounced antinociceptive effects rather than each isolated treatment in a neuropathic pain model; and if the antinociceptive effects are involved with neurochemical biomarkers central levels.
Materials and methods

Animals
Male Wistar rats (n=156; 8 weeks old, weight 280 ± 20 g) were randomly assigned by weight and housed in polypropylene cages (49 × 34 × 16 cm) with sawdustcovered flooring. All rats were maintained in a controlled environment (23 ± 2ºC) with a standard light-dark cycle (12 h/12 h) with water and chow ad libitum. The sample size was calculated to detect the statistical significance between means considering an alpha=0.05 and power of 90% [23] [24] [25] . All experiments were approved by the Institutional Animal Care and Use Committee (GPPG-HCPA no. 20170061) and met the ethical and methodological ARRIVE guidelines [26] .
Experimental design
Rats were initially divided into three groups: Control, Sham-Pain and Pain. In the 14th day the rats were subdivided into thirteen groups: Control-Group (C), Sham-Pain (S), at baseline, 7, and 14 days after CCI procedure, and immediately, 24 h, and 7 days posttreatments. First, bimodal tDCS was performed; after that, rats were made to exercise on a treadmill from days 15 to 22 post-CCI. Rats were killed by decapitation at 48 h and 7 days after treatment completion ( Fig. 1 ).
Sham
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Neuropathic pain model
Animals were anesthetized with isoflurane (5% for induction, 2.5% for maintenance) and placed in the lateral decubitus for hair shaving and skin antisepsis with 2% alcohol as described in an earlier study [27] . After skin incision in the middle third of the left hind limb to expose the biceps femoralis muscle, the common sciatic nerve was exposed and three ligatures were tied (Vycril 4.0) with minor modifications [25] . For sham groups, the sciatic nerve was similarly exposed, but the nerve was not ligated. The same investigator performed the ligatures in all rats. After surgery, the wound was sutured using Mononylon 4.0 and the rats (Sham and CCI groups) received tramadol intraperitoneally during the first 3 days post-surgery (7:00 am and 7:00 pm) to minimize excessive suffering.
tDCS protocol
Fourteen days post-surgery, the rats were submitted to a twenty-minute session of bimodal tDCS treatment for eight consecutive days in a constant direct current of 0.5 mA delivered from a battery-powered stimulation source, as described in a previous method [28] . Rats subjected to active or sham stimulation had their scalp shaved. The electrode size was trimmed to 1.5 cm 2 and a constant current intensity of 0.5mA was applied upon the scalp. It provided a current density of 0.33 mA/cm 2 with no lesions previously reported [23, 29] . The anode was placed on the head using landmarks of the neck and shoulder lines as a guide (the anterior and posterior regions of the midline between the two hemispheres of the parietal cortex), while the cathode was positioned at the midpoint between the lateral angles of both eyes (supraorbital area). For the sham groups, the electrodes were placed and fixed in the same position as for active stimulation; however, the stimulator remained turned off throughout the experiments.
Exercise protocol
One week before surgery, the rats were habituated daily on a treadmill. On day 1, rats were placed for 20 minutes on a turned-off treadmill to recognize a new apparatus. Next, the rats were gradually conditioned to run by increasing the exposure time on the treadmill from 10 to 20 and 30 minutes at days 2, 3, and 4, respectively, at low speed (5 m/min). On day 5, we used an indirect method to determine the VO 2max [30] . Briefly, the rats ran at 7 m/min for 3 minutes, with an increase of speed at 5 m/min until the point of exhaustion, perceived as the incapacity to continue running. The time to fatigue (in min) and workload (in m/min) were obtained as indexes of aerobic capacity, which, in turn, were taken as VO 2max . The exercise protocol consisted of running sessions at 70% of VO 2max . The rats were subjected to one 20-min running session daily for 8 days (08:00 -09:30 am) on a 0° slope. No electric shocks were delivered to incite them to run.
Nociceptive tests
Mechanical allodynia
We used an automatic von Frey aesthesiometer (Insight, São Paulo, Brazil) to assess mechanical hyperalgesia. Rats were habituated in polypropylene cages (12 × 20 × analgesia induced by novelty [31] . For testing, a polypropylene tip was applied underneath the floor grid and between the five distal foot pads, gradually increasing the pressure. Measurements were assessed in triplicate and means were expressed in grams (g) per paw withdrawal.
Thermal hyperalgesia
All rats were exposed to a hot plate (HP) for 5 minutes, 24h prior to the test in order to avoid analgesia induced by novelty [31] . On the test day, the surface of the hot plate was pre-heated and kept at a constant temperature (55 ± 0.1ºC). The rats were placed on the heated surface surrounded by glass funnels. The time in seconds for the first behavioral response (foot-licking, jumping, or rapidly removing paws) was recorded as the latency of nociceptive response [32] .
Tissue collection
At 48 h or 7 days after the last treatment, rats were killed by decapitation, and tissue samples (cerebral cortex, brainstem, and spinal cord) were harvested. The structures were kept at -80ºC until the assays were performed.
Biochemical assays
Cerebral cortex, spinal cord, and brainstem BDNF (DY248), IL-1β (DY501) and IL-4 (DY504) levels were determined by sandwich ELISA using monoclonal antibodies (R&D; Minneapolis, MN). The total protein was measured by the Bradford method using bovine serum albumin as a standard [33] . The results were corrected by total protein and expressed in pg/mg of protein.
Statistical analysis
Data were expressed as the mean ± standard error of the mean (S.E.M.).
Generalized estimating equations (GEE) followed by Bonferroni testing was used to analyze behavioral data [34] . For biochemical assays, a four-way ANOVA followed by post-hoc Bonferroni correction was used, considering the interactions between independent variables (pain, tDCS, exercise, time). A p-value < 0.05 was considered significant. Data were analyzed with SPSS for Windows (version 20.0; IBM, Armonk, NY).
Results
Effects of isolated bimodal tDCS treatment or combined with aerobic exercise on mechanical hyperalgesia
We found no difference between groups at baseline (p > 0.05). There was an interaction between group and time in mechanical hyperalgesia as assessed in the von Frey test (Wald's χ 2 = 429,286; p < 0.05, n = 156; Fig. 2A ). From 7 to 14 days post-surgery, all CCI groups displayed marked mechanical hyperalgesia (p < 0.05) compared to control and sham groups. Immediately, 24h, and 7 days post-treatment, the PE, PT, PSE, and PTE groups displayed increased nociceptive thresholds in response to treatment.
Interestingly, at 7 days post-treatment, the PTE group displayed a slightly increase in the nociceptive threshold than the treatment alone (Wald's χ 2 = 1714,912 for group effect and Wald's χ 2 = 10,512 for time effect; p < 0.05, n = 156; Fig. 2C ).
Effects of isolated bimodal tDCS treatment or combined with exercise on thermal hyperalgesia
We found no difference between groups at baseline (p > 0.05). There was an interaction between group and time in thermal hyperalgesia (Wald's χ 2 = 88,462; p < 0.05, n = 156, Fig. 2B ). At 7 days post-surgery, the Sham-Pain groups displayed decreased thermal withdrawal latency, which was even pronounced in the Pain groups.
At 14 days post-surgery, only the Pain groups displayed marked thermal hyperalgesia compared to the Control and Sham-Pain groups (p < 0.05). From immediately to 7 days after the last treatment, all groups subjected to tDCS or exercise alone and to combined treatment showed no thermal hyperalgesia, compared to the P and PS groups (Wald's χ 2 = 153,658 for group effect; p < 0.05, n = 156, Fig. 2D ).
Cerebral cortex BDNF, IL-1β, and IL-4 levels
Regarding cerebral cortex BDNF levels, there was an interaction between pain, tDCS, exercise, and time (four-way ANOVA/Bonferroni, F (2,120) = 5.064, p < 0.01; Table 1 ). At 48h post-treatment, the PT group showed increased BDNF levels compared Regarding cerebral cortex IL-1β levels, there was a main effect of pain (fourway ANOVA/Bonferroni, F (1,120) = 12.168, p < 0.01; Table 1 ). The pain groups displayed increased IL-1β levels in the cerebral cortex compared to the Sham-Pain groups. There was a main effect of time (F (1,120) = 25.444, p < 0.01). Compared to 48h post-treatment, the Pain groups displayed increased IL-1β levels at 7 days posttreatment.
Regarding IL-4 levels, there was an interaction between pain, tDCS, and exercise (four-way ANOVA/Bonferroni, F (2,120) = 5.354, p < 0.01; Table 1 ). The PTE group displayed reduced IL-4 levels compared to the STE group. Moreover, there were interactions between pain, tDCS, and time (F (2, 120) -
Brainstem BDNF, IL-1β, and IL-4 levels
Regarding BDNF levels, there was an interaction between pain, tDCS, and exercise (four-way ANOVA/Bonferroni, F (2,120) = 4.833, p < 0.05; Table 2 ). The PT group displayed decreased BDNF levels compared to the ST group. Moreover, there were interactions between: pain, exercise, and time (F (1,120) = 8.488, p < 0.01); pain and tDCS (F (3, 503) Regarding IL-1β levels, there was an interaction between pain, tDCS, and exercise (four-way ANOVA/Bonferroni, F (2,120) = 5.171, p < 0.01; Table 2 ). The Pain groups displayed increased IL-1β levels compared to the Sham-Pain groups. Moreover, the PS group displayed increased IL-1β levels compared to the SS group; the PE group also displayed increased IL-1β levels compared to the SE group. Furthermore, there were interactions between pain and exercise (F (1,120) = 11.121, p < 0.001) and pain and time (F (1,120) = 5.578, p < 0.05). There was a main effect of pain (F (1,120) = 17.092, p < 0.001).
Regrading IL-4 levels, there was an interaction between pain, tDCS, and exercise (four-way ANOVA/Bonferroni, F (2,120) = 3.357, p < 0.05; Table 2 ). The Pain, PS, and PT groups showed increased IL-4 levels compared to the Sham-Pain, SS, and ST groups. Moreover, the PTE group showed increased IL-4 levels compared to the STE group. Furthermore, there were interactions between pain, tDCS, and time (F (2,120) = 3.091, p < 0.05); tDCS, exercise, and time (F (2,120) = 3.401, p < 0.05); pain and exercise (F (1,120) = 6.889, p < 0.02); and pain and time (F (1,120) = 5.778, p < 0.02). There were main effects of pain (F (1,120) = 35.294, p < 0.001); tDCS (F (2,120) = 6.369, p < 0.01) and time (F (1,120) = 156.300, p < 0.001).
Spinal cord BDNF, IL-1β, and IL-4 levels
Regarding BDNF levels, there was an interaction between pain, tDCS, exercise, and time (four-way ANOVA/Bonferroni, F (2,120) = 3.150, p < 0.05; Table 3 ). At 48h and Sham-Pain group. At 48h post-treatment, the PS group displayed increased BDNF levels compared to the SS group; the PSE group displayed decreased BDNF levels compared to the SSE group. Furthermore, there were interactions between pain, tDCS, and exercise (F (2,120) = 4.687, p < 0.001); pain, exercise, and time (F (1, 120) Regarding IL-1β levels, there was an interaction between pain and tDCS (fourway ANOVA/Bonferroni, F (2,120) = 5.767, p < 0.01; Table 3 ). The PT groups displayed increased IL-1β levels compared to the ST groups. Moreover, there were interactions between pain and time (F (1,120) = 16.458, p < 0.001) and tDCS and time (F (2,120) = 12.925, p < 0.001). There were main effects of pain (F (1,120) = 49.720, p < 0.001), tDCS (F (2,120) = 6.728, p < 0.01), and time (F (1,120) = 44.936, p < 0.001).
Regarding IL-4 levels, there was an interaction between pain, tDCS, exercise, and time (four-way ANOVA/Bonferroni, F (2,120) = 5.100, p < 0.01; Table 3 
Discussion
In this study, we showed that bimodal tDCS, aerobic exercise, or the combined treatments reverted thermal hyperalgesia in rats subjected to CCI. This effect was associated by a remarkable increase of the nociceptive threshold in all times assessed. tDCS or aerobic exercise alone partially increased the mechanical threshold immediately and 24h after the last treatment. However, the combined treatments only displayed a slight improvement in the mechanical threshold at 7 days after the last treatment. We also showed modulations of central biomarker levels indexed by interactions observed among independent variables (pain, tDCS, exercise, and time) or main effects. The combination of tDCS and exercise has been poorly investigated as an adjuvant treatment against chronic pain. To our knowledge, this is the first study evaluating the combined effect of tDCS and aerobic exercise on nociceptive behavior in a neuropathic chronic pain model.
The differences found in the analgesic response induced by treatments may be related to different pathways activated by mechanical or thermal stimuli; while the first test activates Aβ fibers, the second mainly activates the Aδ and C fibers [35] . Current data corroborate our previous study, which showed that tDCS abolished the thermal hyperalgesia induced by CCI but was less effective on mechanical hyperalgesia [25] . It should be stressed that the central sensitization process triggered by neuropathic pain modulates the activity of wide dynamic range (WDR) neurons in the deepest laminae of the dorsal horn. This occurs in response to injury, contributing to behavioral and electrophysiological changes in chronic pain models [36] . Therefore, we hypothesized that synaptic transmission in neurons of pain pathways is mostly affected by nerve injury.
Numerous studies have used tDCS to treat neurological disorders [37, 38] , and chronic pain [31, 32] . Although the main action mechanism of tDCS remains unclear, its analgesic effects comprise the modulation of a wide range of neurotransmitters, receptors, and ionic channels, including glutamatergic, serotoninergic, GABAergic, cannabinoid, and adenosinergic pathways [9, 33] . Moreover, long-term effects triggered by tDCS are related to the facilitation of long-term potentiation phenomena [41] .
However, exercise can provide both beneficial or detrimental effects [42] . The antinociceptive effects of exercise are mediated by opioid and non-opioid mechanisms, or an interaction between them [16, 36] . Wheel running for 5 days before inducing muscle pain has been reported to prevent the development of activity-induced hyperalgesia through modulation of serotonin transporters, mediated by mu-opioid receptors [44] . Cobianchi et al. [45] showed that short-(from 3 to 7 days post-CCI), but not long-lasting treadmill running, fully reverted mechanical allodynia. In our study, 7 days post-surgery, the Sham-Pain groups still exhibited a mild response to thermal stimulus, implying that inflammatory pain signaling was still occurring.
Consistent with our previous study [46] , the neuromodulatory effects of tDCS on central biomarker levels depended on the structure assessed. For instance, bimodal tDCS increased BDNF in the cerebral cortex but decreased BDNF in the brainstem.
Several connections among midbrain structures might act to affect the pronociceptive process. Such studies hold that descending facilitation involving BDNF/trkB and p38/MAPK signaling pathways throughout the periaqueductal grey (PAG), rostroventromedial medulla (RVM), and spinal cord increases NMDAR phosphorylation to yield a pronociceptive effect [40, 41] .
The top-down effects triggered by tDCS have the ability to modulate peripheral and central cytokine levels. For example, IL-1β and IL-10 levels were changed by tDCS in a model of chronic pain [25] , while in chronically stressed rats, tDCS modulated hippocampal TNF-α levels [28] . Moreover, tDCS decreased mostly interleukin (IL-4, IL-6, IL-10) levels in the serum in depressed patients [49] . These effects demonstrate the ability of tDCS to modulate cytokines levels in cortical and subcortical structures, beyond a humoral response, highlighting that their potential effects might be implicated in biomarker development.
Additionally, exercise reverted the increase in pain-induced BDNF levels in the spinal cord. This corroborates a previous study showing that neurotrophic factors and interleukins are modulated differently in response to exercise [43, 44] . BDNF released from pain-activated glial cells in the spinal cord has been reported to drive a neuronal gradient shift inducing sensitization of primary afferent neurons, which is restored by a BDNF antagonist [52] or exercise [53] .
Our exercise protocol increased IL-4 levels in the brainstem and spinal cord but not in the cerebral cortex. Consistently, Bobinski et al. [54] showed that treadmill exercise increased IL-4 levels in the spinal cord in mice subjected to peripheral nerve injury. The anti-inflammatory and protective properties of IL-4 levels might be related to the preservation of spinal motor pathways through upregulation of arginase-1, IL-10, and CD206+ cells [55] . However, no effect was observed on IL-4 levels in the muscles and nerves in a axonotmesis mouse model after eccentric treadmill exercise [56] .
Therefore, we hypothesize that the pattern of IL-4 expression depends on the exercise protocol (duration and intensity), pain model, and central structure analyzed.
Furthermore, we also showed that IL-1β levels in the brainstem remained high after treadmill exercise. Contrastingly, Bobinski et al. [57] found decreased IL-1β levels in mice subjected to treadmill exercise. However, our exercise protocol began 15 days post-injury and lasted for 8 days, whereas their protocol began 3 days post-surgery and lasted for 10 days.
We also showed that exercise and/or tDCS modulates the hyperalgesic response and inflammatory profile in rats subjected to neuropathic pain. The reduction of the hypernociceptive response occurred from immediately to 7 days after the end of treatment (21 days post-surgery). However, we found no synergic effects between tDCS and aerobic exercise on the mechanical threshold in the short-term, but only a slight improvement in the long-term. Contrastingly, we showed a full reversal in thermal hyperalgesia. These discrepancies might be due to unknown mechanisms by which both treatments interact when applied in association [58] . Another explanation for such results is a ceiling effect, probably involving similar mechanisms between treatments [33, 52] . Beyond that, it should be noted that exercise imposes stress upon the hypothalamic-pituitary-adrenal axis [60] . Therefore, we cannot rule out that our employed protocol (treadmill exercise) had a stressor component, and that it may have interfered with the short-term effects. Contrastingly, a randomized placebo-controlled clinical trial has shown that tDCS to the primary motor cortex (M1) simultaneously applied with aerobic exercise reduced pain-related outcomes in human females with fibromyalgia [61] . We also found that the combined treatments increased BDNF and IL-4 levels in the rat cerebral cortex and brainstem, respectively. However, the combined treatments decreased IL-4 levels in the cerebral cortex. An explanation for that might be attributed to a structure-dependent function or interaction among pathways involved in exercise and/or tDCS mechanisms. More studies are required to elucidate the underlying mechanisms of combining these therapies and their effect on pain-related outcomes.
Our study has some limitations. Firstly, we only assessed the outcomes related to chronic pain in males, not females. Secondly, our protocol for VO 2max determination was based on an indirect method, and it is possible that some animals ran slightly above or below the maximal lactate steady state. Thirdly, the small head size of the rat and the restraint required for tDCS application allowed for only bimodal stimulation.
Conclusions
Our study showed that tDCS and aerobic exercise can treat chronic pain. According with Figure 3 , it is possible to observe the neuroimmunomodulatory effects of the therapies applied. Both methods are safe, inexpensive, and accessible strategies in chronic pain management by reducing the side effects of a sedentary lifestyle, and providing whole-body benefits. To date, most studies have focused on non-specific drugs that trigger several side effects in addition to not treating the pathology.
Therefore, tDCS or exercise treatments should take into account the situation of each individual, while adjusting parameters to produce more efficient results (stimulation intensity vs. exercise intensity; time to stimulation vs. exercise). More studies are required to elucidate how tDCS and exercise might be applied more efficiently and whether both interventions may be used as a treatment approach. Nociceptive tests were von Frey and hot plate to assess mechanical and thermal hyperalgesia, respectively. Bimodal tDCS and/or treadmill exercise was provided from 15th to 22nd days after CCI. 
